History

• Appalachian Biosciences established in 2015 to develop novel monoclonal antibodies
• October 2013 – December 2017 - The Nashville site operated as an internal manufacturing site for Berg, LLC
  • Manufactured small molecule clinical supplies
    • Phase I and Phase II in US for parenteral, oral liquid, topical cream, and topical solution
    • April 2017 received QP declaration for Phase II parenteral product for use in EU clinical trial
  • Small and large molecule development
• PMI Biopharma Solutions, LLC was established in January 2018 by Pathfinder Management, Inc as the major investor